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Glioblastoma is one of the most malignant cancer types. Its
median survival is 15 months with combined radio- and
chemotherapy and only 4 months without therapy. Molecular
chaperones play a very multifaced role in tumor development.
Depletion of Hdj1 in cancer cells accelerates tumor growth.
Decrease of Hdj2 level correlates with the increase of tumor
aggressiveness, but also attenuates tumor protection against
radiotherapy. Hsp70 provides considerable survival advantages
to the cancer cells, but at the same time can act as a
‘‘chaperokine”, activating antitumoral immunity. For assessment
of chaperone’s role in glioma progression, invasiveness and
metastasis formation we chose rat model of intracranial injection
of 105 C6 cells. We developed three C6-based cell lines with
protein knock-down by RNA-interference: C6 shHsp70 (on 83%),
C6 shHdj1 (on 96%) and C6 shHdj2 (on 52%). The last differed in
roundish and easily detachable morphology. Following intracra-
nial injection of the modified tumor cells, the animals’ survival
was estimated. As compared to the groups of control C6 (25.4
± 3.9 days) and C6 shHdj1 (25.5 ± 3.8) we observed a nearly 1.5-
fold decrease in survival in C6 shHdj2 (16.8 ± 3.5 days) (P < 0.05).
On the contrary, in C6 shHsp70 group the survival increased up
to 42.5 ± 12.0 days (the increase is completely explainable by the
slower growth rate of the culture). Subsequent MR imaging and
histological analysis of tumors demonstrated elevated invasive-
ness and metastatic activity in C6 shHdj2 group in comparison
to C6 shHsp70, C6 shHdj1 and control C6. High migration activity
and the ability of floating C6 shHdj2 cells to adhere and settle on
the substrate was proved in wound-healing assay, spot-healing
assay, colony forming assay and transwell migration assay. Adhe-
sion assay showed decreased adhesion ability of C6 shHdj2 cells
and increased – of C6 shHsp70 cells on all types of tested extracel-
lular matrixes. Immunofluorescence analyses showed loss of
membrane- expressed N-cadherin and loss of intercellular con-
tacts mediated by N-cadherin in C6 shHdj2 cells in comparison
to other considered cell lines (although its level in western blot
was elevated). Actin staining with rhodamine-falloidin revealed
highly abundant leading edges in C6 shHdj2 culture. Matrix met-
alloprotease zymography proved an increased activity in gelati-
nases (mmp2 and mmp9) as well as in caseinases (mmp1 and
mmp8) in C6 shHdj2 culture supernatant. Assay of stemness mar-
ker CD133 expression showed its 11.8 times increase in C6 shHdj2.
Our experiments proved the high importance of Hdj2 level in
glioma progression, invasion and metastasis.
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Background: multidrug resistance (MDR) remains a major
problem in the fight against tumors. MDR – multidimensional
phenomenon, which occurs as a consequence of activation of
several systems, associated both with the release of xenobiotics
from the cell by ABC-transporters, and with stimulation of path-
ways that enhance cell survival. One of the possible regulators of
MDR is multifunctional protein YB-1. YB-1 acting as a transcrip-
tion factor in cell’s nucleus, can upregulate expression of MDR1,
as well as some other ABC-transporters genes. Furthermore, YB-
1 is secreted by cells and binds to the protein Notch3, and that
stimulates proliferation and migration of cells. Also, resistance
of cells may increase upon stimulation of VEGF-VEGER systems.
Our aim was to study the mechanisms of MDR at various levels
in the pairs of parental and resistant breast cancer cells: changes
in the expression and localization of YB-1, evaluation expression
of ABC-transporters, activation of protein Notch, as well as
changes in the VEGF system.
Materials and methods: Long-term cultivation of cells MCF-7
(breast adenocarcinoma) and HBL-100 (transformed cells) in the
presence of doxorubicin to obtain resistant sublines, MTT assay,
real-time PCR, immunocytochemistry, flow cytofluorometry.
Results: we obtained the sublines of cells MCF-7 and HBL-
100 resistant to doxorubicin: MCF-7/D7 and HBL-100/D85,
respectively. The level of resistance to doxorubicin in resistant
MCF-7/D6 was 7 times higher than in parent MCF-7 (IC50 was
0.7 ± 0.01 mcM vs 0.1 ± 0.002 mcM, respectively), and the level
of resistance HBL-100/D85 was 44.7 times higher than the
HBL-100 (IC50 8.5 ± 0.17 mcM vs 0.19 ± 0.03 mcM). Also, MCF-7/
D7 acquired cross-resistance to cisplatin (6.7 ± 0.1 mcM vs
48 ± 0.2 mcM) and paclitaxel (2 ± 0.03 nM vs 50 ± 1 nM), but
not to vinblastine and 5-fluorouracil, and HBL-100/D85 – about
100 times to paclitaxel (13 ± 0.2 nM vs 1100 ± 19 nM) and vin-
blastine (2.4 ± 0.3 nM vs 250 ± 5 nM), but not to the cisplatin
and 5-fluorouracil. The expression profile of ABC-transporter
genes showed significant activation of the MDR1 expression
in subline HBL-100/D85 (more than 1000 times), but not in
MCF-7/D6.
Expression of other genes of the family ABC-transporters -
MRP1, BCRP, MVP - increased slightly. Expression of mRNA YB-1
was almost unchanged. YB-1 protein detected in cytoplasm of
parental lines, but it detected in nuclei in resistant sublines. Also,
protein Notch3 translocated from membrane into nucleus. Evalu-
ation of VEGF expression profile revealed that in a couple of
VEGFA-VEGFR2 didn’t occur any changes. However, we observed
a significant upregulation of expression mRNA VEGFC and
down-regulation of mRNA VEGFR3 in resistant sublines MCF-7/
D6 and HBL-100/D85.
Conclusion: the results of our study show that the appear-
ance of MDR associated with various changes in cells. Com-
mon changes in the resistant sublines were translocation of
protein YB-1 and Notch3 in cells nuclei, as well as the dynam-
ics of expression changes in pair VEGFCVEGFR3.The last obser-
vation is an interesting finding and requires more detailed
study.
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